After years of lawsuits against agrichemical companies and battles over environmental regulations, the nation’s highest court is expected to rule this summer on a case that could significantly alter the pesticide industry.
Critics say the structure of the deal provides a rich payout of $675 million in fees to the lawyers helping promote the deal, but paltry payments for the cancer sufferers who make up the class.
This story was originally published by The New Lede.
In an opening salvo aimed at convincing the U.S. Supreme Court to curtail costly Roundup litigation, Bayer is citing support
